{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:07Z","timestamp":1788480487142,"version":"build-2803163510"},"reference-count":60,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arrhythm Electrophysiol Rev"],"abstract":"<jats:p>Pulsed field ablation (PFA) for AF has changed the landscape of AF treatment globally. While clinical trial data have shown non-inferiority compared with thermal ablation, the safety profile of this technology is still being understood. Large post-approval registry data are now accumulating and have invariably demonstrated that rather than PFA being necessarily safer than conventional thermal ablation, the safety profile is simply different. Pericardial tamponade remains a risk and may even be greater compared with thermal ablation. Coronary artery spasm has been recognised, particularly with off-label use of PFA. Haemolysis and associated acute kidney injury are unique complications related to PFA. Stroke risk persists with likely multiple causes. Other complications, such as femoral venous injury, vagal responses and transient phrenic nerve injury, are increasingly recognised. In this review, we summarise recent data regarding potential complications associated with PFA, including mechanisms, risk factors, management and prevention.<\/jats:p>","DOI":"10.15420\/aer.2025.54","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:28:20Z","timestamp":1776443300000},"source":"Crossref","is-referenced-by-count":2,"title":["A Review of Potential Complications of Pulsed Field Ablation for AF: Beneath the Surface"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3206-5725","authenticated-orcid":false,"given":"Francis J","family":"Ha","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2210-5773","authenticated-orcid":false,"given":"Tai","family":"Ermongkonchai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-5784","authenticated-orcid":false,"given":"Hui-Chen","family":"Han","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-8648","authenticated-orcid":false,"given":"Nitesh","family":"Nerlekar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-6052","authenticated-orcid":false,"given":"Adam J","family":"Brown","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-7825","authenticated-orcid":false,"given":"Emily","family":"Kotschet","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02t1bej08","id-type":"ROR","asserted-by":"publisher"}],"name":"Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Anter E, Mansour M, Nair DG, et al. Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial. Nat Med 2024;30:2303\u201310. https:\/\/doi.org\/10.1038\/s41591-024-03022-6; PMID:\u00a038760584.","DOI":"10.1038\/s41591-024-03022-6"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Reichlin T, Kueffer T, Badertscher P, et al. Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation. N Engl J Med 2025;392:1497\u2013507. https:\/\/doi.org\/10.1056\/NEJMoa2502280; PMID:\u00a040162734.","DOI":"10.1056\/NEJMoa2502280"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023;389:1660\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2307291; PMID:\u00a037634148.","DOI":"10.1056\/NEJMoa2307291"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kos B, Reber\u0161ek M, Miklav\u010di\u010d D. Complexity and perplexity of pulsed field ablation: an engineering perspective. Arrhythm Electrophysiol Rev 2025;14:e24. https:\/\/doi.org\/10.15420\/aer.2025.37; PMID:\u00a041208822.","DOI":"10.15420\/aer.2025.37"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Neven K, F\u00fcting A, Hartl S, Reinsch N. Durability of pulsed field ablation lesions: current understanding and future directions. Arrhythm Electrophysiol Rev 2025;14:e23. https:\/\/doi.org\/10.15420\/aer.2025.36; PMID:\u00a041208821.","DOI":"10.15420\/aer.2025.36"},{"key":"ref5","unstructured":"Ekanem E, Neuzil P, Reichlin T, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med 2024;30:2020\u20139. https:\/\/doi.org\/10.1038\/s41591-024-03114-3; PMID:\u00a038977913."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 2021;7:614\u201327. https:\/\/doi.org\/10.1016\/j.jacep.2021.02.014; PMID:\u00a033933412.","DOI":"10.1016\/j.jacep.2021.02.014"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Duytschaever M, De Potter T, Grimaldi M, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol 2023;16:e011780. https:\/\/doi.org\/10.1161\/circep.122.011780; PMID:\u00a036735937.","DOI":"10.1161\/CIRCEP.122.011780"},{"key":"ref8","unstructured":"Chaumont C, Laredo M, Thomas O, et al. Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: acute results from the FRANCE-PFA registry. Heart Rhythm 2025;6:911\u20139. https:\/\/doi.org\/10.1016\/j.hroo.2025.04.005; PMID:\u00a040734736."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Schmidt B, Bordignon S, Neven K, et al. EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace 2023;25:euad185. https:\/\/doi.org\/10.1093\/europace\/euad185; PMID:\u00a037379528.","DOI":"10.1093\/europace\/euad185"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"de Campos MCAV, Moraes VRY, Daher RF, et al. Pulsed-field ablation versus thermal ablation for atrial fibrillation: a meta-analysis. Heart Rhythm 2024;5:385\u201395. https:\/\/doi.org\/10.1016\/j.hroo.2024.04.012; PMID:\u00a038984363.","DOI":"10.1016\/j.hroo.2024.04.012"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ha FJ, Prinsloo D, Xu E, et al. Procedural and clinical outcomes of pulsed field ablation for atrial fibrillation in female patients: an observational study at a large tertiary centre in Australia. J Interv Card Electrophysiol 2025. https:\/\/doi.org\/10.1007\/s10840-025-02167-9; PMID:\u00a041258273.","DOI":"10.1007\/s10840-025-02167-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sugrue A, Shabtaie S, Tan NY, et al. Considerations regarding safety with pulsed field ablation for atrial fibrillation. Heart Rhythm 2024;5:655\u201361. https:\/\/doi.org\/10.1016\/j.hroo.2024.08.002; PMID:\u00a039493907.","DOI":"10.1016\/j.hroo.2024.08.002"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kamsani SH, Emami M, Young GD, et al. First-in-human experience of high-energy ElectroPulse pulsed field ablation: acute results for pulmonary veins and posterior wall isolation. Heart Rhythm 2025;22:e309\u201317. https:\/\/doi.org\/10.1016\/j.hrthm.2024.10.070; PMID:\u00a039515499.","DOI":"10.1016\/j.hrthm.2024.10.070"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lakkireddy D, Katapadi A, Garg J, et al. NEMESIS-PFA: investigating collateral tissue injury associated with pulsed field ablation. JACC Clin Electrophysiol 2025;11:1747\u201356. https:\/\/doi.org\/10.1016\/j.jacep.2025.04.017; PMID:\u00a040392666.","DOI":"10.1016\/j.jacep.2025.04.017"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Tilz RR, Chierchia GB, Gunawardene M, et al. Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results. Europace 2025;27:euaf072. https:\/\/doi.org\/10.1093\/europace\/euaf072; PMID:\u00a040163671.","DOI":"10.1093\/europace\/euaf072"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Reddy VY, Anter E, Peichl P, et al. First-in-human clinical series of a novel conformable large-lattice pulsed field ablation catheter for pulmonary vein isolation. Europace 2024;26:euae090. https:\/\/doi.org\/10.1093\/europace\/euae090; PMID:\u00a038584468.","DOI":"10.1093\/europace\/euae090"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Calkins H, Kuck KH, Cappato R, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012;33:171\u2013257. https:\/\/doi.org\/10.1007\/s10840-012-9672-7; PMID:\u00a022382715.","DOI":"10.1007\/s10840-012-9672-7"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Metzner A, Sultan A, Futyma P, et al. Prevention and treatment of pericardial tamponade in the electrophysiology laboratory: a European Heart Rhythm Association survey. Europace 2023;26:euad378. https:\/\/doi.org\/10.1093\/europace\/euad378; PMID:\u00a038163951.","DOI":"10.1093\/europace\/euad378"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Higuchi S, Gerstenfeld EP. Coronary artery injury in pulsed field ablation. Curr Opin Cardiol 2025;40:22\u201330. https:\/\/doi.org\/10.1097\/HCO.0000000000001181; PMID:\u00a039633559.","DOI":"10.1097\/HCO.0000000000001181"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Reddy VY, Petru J, Funasako M, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation 2022;146:1808\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061497; PMID:\u00a036134574.","DOI":"10.1161\/CIRCULATIONAHA.122.061497"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhang C, Neuzil P, Petru J, et al. Coronary artery spasm during pulsed field vs radiofrequency catheter ablation of the mitral isthmus. JAMA Cardiol 2024;9:72\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2023.4405; PMID:\u00a038019505.","DOI":"10.1001\/jamacardio.2023.4405"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Luther V, Chiong J, James C, et al. Diffuse right coronary artery spasm occurring 45 minutes after pulsed field ablation for atrial fibrillation. Heart Rhythm 2025;22:1864\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2025.03.1978; PMID:\u00a040147721.","DOI":"10.1016\/j.hrthm.2025.03.1978"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Mannion J, Gorry C, Foley B, Tuohy S. Remote diffuse multi-coronary artery spasm following pulmonary vein and posterior wall isolation, using a focal monopolar pulsed field ablation catheter. HeartRhythm Case Rep 2025;11:1113\u20139. https:\/\/doi.org\/10.1016\/j.hrcr.2025.08.003; PMID:\u00a041333857.","DOI":"10.1016\/j.hrcr.2025.08.003"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Nakamura T, Takami M, Fukuzawa K, et al. Incidence and characteristics of coronary artery spasms related to atrial fibrillation ablation procedures \u2013 large-scale multicenter analysis. Circ J 2021;85:264\u201371. https:\/\/doi.org\/10.1253\/circj.CJ-20-1096; PMID:\u00a033431721.","DOI":"10.1253\/circj.CJ-20-1096"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Malyshev Y, Neuzil P, Petru J, et al. Nitroglycerin to ameliorate coronary artery spasm during focal pulsed-field ablation for atrial fibrillation. JACC Clin Electrophysiol 2024;10:885\u201396. https:\/\/doi.org\/10.1016\/j.jacep.2023.12.015; PMID:\u00a038385916.","DOI":"10.1016\/j.jacep.2023.12.015"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Reddy VY, Gerstenfeld EP, Schmidt B, et al. Pulsed field ablation of persistent atrial fibrillation with continuous electrocardiographic monitoring follow-up: ADVANTAGE AF Phase 2. Circulation 2025;152:27\u201340. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074485; PMID:\u00a040273320.","DOI":"10.1161\/CIRCULATIONAHA.125.074485"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Gunawardene MA, Hartmann J, Tigges E, et al. Word of caution: clinically apparent coronary spasm following pulsed field cavotricuspid isthmus ablation despite nitroglycerin prophylaxis - a case report. Eur Heart J Case Rep 2024;8:ytae553. https:\/\/doi.org\/10.1093\/ehjcr\/ytae553; PMID:\u00a039545158.","DOI":"10.1093\/ehjcr\/ytae553"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Koruth JS, Kawamura I, Buck E, et al. Coronary arterial spasm and pulsed field ablation: preclinical insights. JACC Clin Electrophysiol 2022;8:1579\u201380. https:\/\/doi.org\/10.1016\/j.jacep.2022.06.015; PMID:\u00a036543509.","DOI":"10.1016\/j.jacep.2022.06.015"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Higuchi S, Im SI, Stillson C, et al. Effect of epicardial pulsed field ablation directly on coronary arteries. JACC Clin Electrophysiol 2022;8:1486\u201396. https:\/\/doi.org\/10.1016\/j.jacep.2022.09.003; PMID:\u00a036779624.","DOI":"10.1016\/j.jacep.2022.09.003"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Tam MTK, Chan JYS, Chan CP, et al. Effect of pulsed-field ablation on human coronary arteries: a longitudinal study with intracoronary imaging. JACC Clin Electrophysiol 2025;11:1478\u201388. https:\/\/doi.org\/10.1016\/j.jacep.2025.03.014; PMID:\u00a040278817.","DOI":"10.1016\/j.jacep.2025.03.014"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Popa MA, Venier S, Men\u00e8 R, et al. Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis. Circ Arrhythm Electrophysiol 2024;17:e012732. https:\/\/doi.org\/10.1161\/circep.124.012732; PMID:\u00a039212069.","DOI":"10.1161\/CIRCEP.124.012732"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Nies M, Koruth JS, Ml\u010dek M, et al. Hemolysis after pulsed field ablation: impact of lesion number and catheter-tissue contact. Circ Arrhythm Electrophysiol 2024;17:e012765. https:\/\/doi.org\/10.1161\/circep.124.012765; PMID:\u00a038651357.","DOI":"10.1161\/CIRCEP.124.012765"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"De Smet MAJ, Fran\u00e7ois C, De Becker B, et al. Intravascular haemolysis and acute kidney injury following atrial fibrillation ablation: a report using two different systems for pulsed field ablation. Europace 2024;26:euae251. https:\/\/doi.org\/10.1093\/europace\/euae251; PMID:\u00a039351957.","DOI":"10.1093\/europace\/euae251"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Deuel JW, Schaer CA, Boretti FS, et al. Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response. Cell Death Dis 2016;7:e2064. https:\/\/doi.org\/10.1038\/cddis.2015.392; PMID:\u00a026794659.","DOI":"10.1038\/cddis.2015.392"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Venier S, Vaxelaire N, Jacon P, et al. Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation. Europace 2023;26:euad371. https:\/\/doi.org\/10.1093\/europace\/euad371; PMID:\u00a038175788.","DOI":"10.1093\/europace\/euad371"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Mohanty S, Casella M, Compagnucci P, et al. Acute kidney injury resulting from hemoglobinuria after pulsed-field ablation in atrial fibrillation: is it preventable? JACC Clin Electrophysiol 2024;10:709\u201315. https:\/\/doi.org\/10.1016\/j.jacep.2023.12.008; PMID:\u00a038310489.","DOI":"10.1016\/j.jacep.2023.12.008"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Nakagawa H, Castellvi Q, Neal R, et al. Effects of contact force on lesion size during pulsed field catheter ablation: histochemical characterization of ventricular lesion boundaries. Circ Arrhythm Electrophysiol 2024;17:e012026. https:\/\/doi.org\/10.1161\/circep.123.012026; PMID:\u00a038152949.","DOI":"10.1161\/CIRCEP.123.012026"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"La Fazia VM, Mohanty S, Torlapati PG, et al. Hydration to prevent kidney injury after pulsed field ablation: importance of timing and fluids amount. JACC Clin Electrophysiol 2025;11:599\u2013601. https:\/\/doi.org\/10.1016\/j.jacep.2024.11.001; PMID:\u00a039718527.","DOI":"10.1016\/j.jacep.2024.11.001"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 2013;128:2104\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003862; PMID:\u00a024061087.","DOI":"10.1161\/CIRCULATIONAHA.113.003862"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Patel C, Gerstenfeld EP, Gupta SK, et al. Comparison of cerebral safety after atrial fibrillation using pulsed field and thermal ablation: results of the neurological assessment subgroup in the advent trial. Heart Rhythm 2024;21:2103\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2024.05.048; PMID:\u00a038823667.","DOI":"10.1016\/j.hrthm.2024.05.048"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Verma A, Haines DE, Boersma LV, et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 2023;147:1422\u201332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.063988; PMID:\u00a036877118.","DOI":"10.1161\/CIRCULATIONAHA.123.063988"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Miyazaki S, Kawamura I, Iwasa Y, et al. Different incidence and size of silent strokes after pulsed field ablation with circular shaped ablation catheters. Circ Arrhythm Electrophysiol 2025;18:e013719. https:\/\/doi.org\/10.1161\/circep.125.013719; PMID:\u00a040270255.","DOI":"10.1161\/CIRCEP.125.013719"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Calvert P, Kollias G, P\u00fcrerfellner H, et al. Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review. Europace 2023;25:euad151. https:\/\/doi.org\/10.1093\/europace\/euad151; PMID:\u00a037306314.","DOI":"10.1093\/europace\/euad151"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Dimitrov JD, Roumenina LT, Perrella G, Rayes J. Basic mechanisms of hemolysis-associated thrombo-inflammation and immune dysregulation. Arterioscler Thromb Vasc Biol 2023;43:1349\u201361. https:\/\/doi.org\/10.1161\/ATVBAHA.123.318780; PMID:\u00a037317847.","DOI":"10.1161\/ATVBAHA.123.318780"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Osmancik P, Bacova B, Hozman M, et al. Myocardial damage, inflammation, coagulation, and platelet activity during catheter ablation using radiofrequency and pulsed-field energy. JACC Clin Electrophysiol 2024;10:463\u201374. https:\/\/doi.org\/10.1016\/j.jacep.2023.11.001; PMID:\u00a038085214.","DOI":"10.1016\/j.jacep.2023.11.001"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Ma C, Xiao X, Chen Q, et al. Intraprocedural activated clotting time and heparin dosage in pulsed field ablation of paroxysmal atrial fibrillation. Front Cardiovasc Med 2025;12:1501716. https:\/\/doi.org\/10.3389\/fcvm.2025.1501716; PMID:\u00a040066349.","DOI":"10.3389\/fcvm.2025.1501716"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Wang K, Wang Z, Jin C, et al. Impact of silent cerebral embolism during and after left atrial appendage occlusion on long-term cognitive function. J Am Heart Assoc 2025;14:e037968. https:\/\/doi.org\/10.1161\/jaha.124.037968; PMID:\u00a039895537.","DOI":"10.1161\/JAHA.124.037968"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Mountantonakis SE, Gerstenfeld EP, Mansour M, et al. Predictors of atrial fibrillation freedom postablation with the pentaspline pulsed field ablation catheter: subanalysis of the ADVENT Study. Heart Rhythm 2025;22:e318\u201327. https:\/\/doi.org\/10.1016\/j.hrthm.2025.03.161; PMID:\u00a040057295.","DOI":"10.1016\/j.hrthm.2025.03.161"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Tzeis S, Gerstenfeld EP, Kalman J, et al. 2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2024;26;euae043. PMID:\u00a038587017.","DOI":"10.1016\/j.hrthm.2024.03.017"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Benali K, Khairy P, Hammache N, et al. Procedure-related complications of catheter ablation for atrial fibrillation. J Am Coll Cardiol 2023;81:2089\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.418; PMID:\u00a037225362.","DOI":"10.1016\/j.jacc.2023.03.418"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Baman TS, Jongnarangsin K, Chugh A, et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2011;22:626\u201331. https:\/\/doi.org\/10.1111\/j.1540-8167.2010.01995.x; PMID:\u00a021235674.","DOI":"10.1111\/j.1540-8167.2010.01995.x"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Jolly SS, AlRashidi S, d\u2019Entremont MA, et al. Routine ultrasonography guidance for femoral vascular access for cardiac procedures: the UNIVERSAL randomized clinical trial. JAMA Cardiol 2022;7:1110\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2022.3399; PMID:\u00a036116089.","DOI":"10.1001\/jamacardio.2022.3399"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Kupo P, Riesz TJ, Saghy L, et al. Ultrasound guidance for femoral venous access in patients undergoing pulmonary vein isolation: a quasi-randomized study. J Cardiovasc Electrophysiol 2023;34:1177\u201382. https:\/\/doi.org\/10.1111\/jce.15893; PMID:\u00a036942777.","DOI":"10.1111\/jce.15893"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Tilz RR, Feher M, Vogler J, et al. Venous vascular closure system vs. figure-of-eight suture following atrial fibrillation ablation: the STYLE-AF Study. Europace 2024;26:euae105. https:\/\/doi.org\/10.1093\/europace\/euae105; PMID:\u00a038647070.","DOI":"10.1093\/europace\/euae105"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Dashwood A, Ha FJ, Healy S, et al. Vascular closure device following pulsed field ablation for atrial fibrillation: a randomized controlled trial. Pacing Clin Electrophysiol 2025;48:1294\u2013300. https:\/\/doi.org\/10.1111\/pace.70051; PMID:\u00a040985473.","DOI":"10.1111\/pace.70051"},{"key":"ref56","unstructured":"Giampaolo Vetta M, Della Rocca DG, Magnocavallo M, et al. Efficacy and drug-related complications of anticholinergic drugs for vagal reaction prevention during pulsed field ablation. JACC Clin Electrophysiol 2025;11:1757\u201368. https:\/\/doi.org\/10.1016\/j.jacep.2025.04.015; PMID:\u00a040392662."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Hu F, Zheng L, Liu S, et al. Avoidance of vagal response during circumferential pulmonary vein isolation: effect of initiating isolation from right anterior ganglionated plexi. Circ Arrhythm Electrophysiol 2019;12:e007811. https:\/\/doi.org\/10.1161\/circep.119.007811; PMID:\u00a031760820.","DOI":"10.1161\/CIRCEP.119.007811"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Del Monte A, Della Rocca DG, Pannone L, et al. Pulsed field ablation of the right superior pulmonary vein prevents vagal responses via anterior right ganglionated plexus modulation. Heart Rhythm 2024;21:780\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2024.01.040; PMID:\u00a038290688.","DOI":"10.1016\/j.hrthm.2024.01.040"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Ch\u00e9hirlian L, Koutbi L, Mancini J, et al. High incidence of phrenic nerve injury in patients undergoing pulsed field ablation for atrial fibrillation. Heart Rhythm 2025;22:e1206\u201313. https:\/\/doi.org\/10.1016\/j.hrthm.2025.08.010; PMID:\u00a040789463.","DOI":"10.1016\/j.hrthm.2025.08.010"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"link":[{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2025.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:28:36Z","timestamp":1776443316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2025.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":60,"URL":"https:\/\/doi.org\/10.15420\/aer.2025.54","relation":{},"ISSN":["2050-3369","2050-3377"],"issn-type":[{"value":"2050-3369","type":"print"},{"value":"2050-3377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"e13"}}